Variant report
Variant | esv3394518 |
---|---|
Chromosome Location | chr8:130497320-130498518 |
allele | n/a |
Outlinks | Ensembl   UCSC |
- TF binding region (count:9)
- CpG islands (count:0)
- Chromatin interactive region (count:0)
- LncRNA region (count:0)
- Mature miRNA region (count: 0)
- miRNA target sites (count:0)
(count:9 , 50 per page) page:
1
No. | Transcrition factor | Chromosome Location | Cell Line | Cell type | Cell Stage | Matched TF binding sites |
---|---|---|---|---|---|---|
1 | BHLHE40 | chr8:130497277-130497416 | K562 | blood: | n/a | n/a |
2 | ELF1 | chr8:130497081-130497442 | K562 | blood: | n/a | n/a |
3 | MAX | chr8:130497172-130497448 | K562 | blood: | n/a | n/a |
4 | POLR2A | chr8:130498035-130498464 | K562 | blood: | n/a | n/a |
5 | POLR2A | chr8:130496865-130497430 | K562 | blood: | n/a | n/a |
6 | POLR2A | chr8:130495968-130497490 | K562 | blood: | n/a | n/a |
7 | POLR2A | chr8:130498065-130498228 | GM12878 | blood: | n/a | n/a |
8 | SPI1 | chr8:130494538-130497621 | HL-60 | blood: | n/a | chr8:130497295-130497308 |
9 | SPI1 | chr8:130497186-130497347 | K562 | blood: | n/a | chr8:130497295-130497308 |
No data |
No data |
No data |
No data |
No data |
Variant related genes | Relation type |
---|---|
MIR3686 | TF binding region |

No. | Variant name | Chromosome position | Chromatin state | Related regulatory elements | Target genes | Extended variants | Associated traits |
---|---|---|---|---|---|---|---|
1 | rs575734386 | chr8:130497330-130497331 | Enhancers Weak transcription Genic enhancers | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
2 | rs202073437 | chr8:130497354-130497355 | Enhancers Weak transcription Genic enhancers | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
3 | rs540622086 | chr8:130497356-130497357 | Enhancers Weak transcription Genic enhancers | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
4 | rs150575920 | chr8:130497420-130497421 | Enhancers Weak transcription Genic enhancers Flanking Active TSS | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
5 | rs561379181 | chr8:130497428-130497429 | Enhancers Weak transcription Genic enhancers Flanking Active TSS | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
6 | rs573244577 | chr8:130497450-130497451 | Enhancers Weak transcription Genic enhancers Flanking Active TSS | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
7 | rs185515775 | chr8:130497456-130497457 | Enhancers Weak transcription Genic enhancers Flanking Active TSS | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
8 | rs139982015 | chr8:130497462-130497463 | Enhancers Weak transcription Genic enhancers Flanking Active TSS | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
9 | rs559542665 | chr8:130497499-130497500 | Enhancers Weak transcription Genic enhancers Flanking Active TSS | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
10 | rs75742368 | chr8:130497542-130497543 | Enhancers Weak transcription Genic enhancers Flanking Active TSS | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
11 | rs199754882 | chr8:130497616-130497617 | Enhancers Weak transcription Genic enhancers | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
12 | rs371585969 | chr8:130497617-130497618 | Enhancers Weak transcription Genic enhancers | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
13 | rs188774836 | chr8:130497618-130497619 | Enhancers Weak transcription Genic enhancers | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
14 | rs376697007 | chr8:130497693-130497694 | Enhancers Weak transcription Genic enhancers | n/a | n/a | Overlapped CNVs | n/a |
15 | rs56374311 | chr8:130497759-130497760 | Enhancers Weak transcription Genic enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
16 | rs11778784 | chr8:130497766-130497767 | Enhancers Weak transcription Genic enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
17 | rs191315048 | chr8:130497773-130497774 | Enhancers Weak transcription Genic enhancers | n/a | n/a | Overlapped CNVs | n/a |
18 | rs183850017 | chr8:130497781-130497782 | Enhancers Weak transcription Genic enhancers | n/a | n/a | Overlapped CNVs | n/a |
19 | rs200931183 | chr8:130497819-130497820 | Enhancers Weak transcription Genic enhancers | n/a | n/a | Overlapped CNVs | n/a |
20 | rs202159778 | chr8:130497856-130497857 | Enhancers Weak transcription Genic enhancers | n/a | n/a | Overlapped CNVs | n/a |
21 | rs567252505 | chr8:130497864-130497865 | Enhancers Weak transcription Genic enhancers | n/a | n/a | Overlapped CNVs | n/a |
22 | rs534761816 | chr8:130497898-130497899 | Enhancers Weak transcription Genic enhancers | n/a | n/a | Overlapped CNVs | n/a |
23 | rs139333837 | chr8:130497937-130497938 | Enhancers Weak transcription Genic enhancers | n/a | n/a | Overlapped CNVs | n/a |
24 | rs551114777 | chr8:130497946-130497947 | Enhancers Weak transcription Genic enhancers | n/a | n/a | Overlapped CNVs | n/a |
25 | rs60235966 | chr8:130497951-130497952 | Enhancers Weak transcription Genic enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
26 | rs538834502 | chr8:130497955-130497956 | Enhancers Weak transcription Genic enhancers | n/a | n/a | Overlapped CNVs | n/a |
27 | rs149903888 | chr8:130497965-130497966 | Enhancers Weak transcription Genic enhancers | n/a | n/a | Overlapped CNVs | n/a |
28 | rs575971766 | chr8:130497976-130497977 | Enhancers Weak transcription Genic enhancers | n/a | n/a | Overlapped CNVs | n/a |
29 | rs536653074 | chr8:130497991-130497992 | Enhancers Weak transcription Genic enhancers | n/a | n/a | Overlapped CNVs | n/a |
30 | rs56023791 | chr8:130497998-130497999 | Enhancers Weak transcription Genic enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
31 | rs569524673 | chr8:130498017-130498018 | Enhancers Weak transcription Genic enhancers | n/a | n/a | Overlapped CNVs | n/a |
32 | rs11987100 | chr8:130498162-130498163 | Enhancers Weak transcription Genic enhancers | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
33 | rs188611367 | chr8:130498174-130498175 | Enhancers Weak transcription Genic enhancers | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
34 | rs573147394 | chr8:130498239-130498240 | Enhancers Weak transcription Genic enhancers | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
35 | rs540757582 | chr8:130498283-130498284 | Enhancers Weak transcription Genic enhancers | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
36 | rs144969683 | chr8:130498337-130498338 | Enhancers Weak transcription Genic enhancers | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
37 | rs181361255 | chr8:130498354-130498355 | Enhancers Weak transcription Genic enhancers | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
38 | rs77509861 | chr8:130498371-130498372 | Enhancers Weak transcription Genic enhancers | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
39 | rs564282263 | chr8:130498373-130498374 | Enhancers Weak transcription Genic enhancers | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
40 | rs116978980 | chr8:130498393-130498394 | Enhancers Weak transcription Genic enhancers | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
41 | rs149020838 | chr8:130498447-130498448 | Weak transcription Genic enhancers | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
42 | rs542508312 | chr8:130498454-130498455 | Weak transcription Genic enhancers | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
43 | rs369088295 | chr8:130498455-130498456 | Weak transcription Genic enhancers | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
44 | rs528057649 | chr8:130498456-130498457 | Weak transcription Genic enhancers | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
45 | rs546700689 | chr8:130498468-130498469 | Weak transcription Genic enhancers | n/a | n/a | Overlapped CNVs | n/a |
46 | rs566310372 | chr8:130498496-130498497 | Weak transcription Genic enhancers | n/a | n/a | Overlapped CNVs | n/a |
Disease | PMID | Source |
---|---|---|
Medulloblastoma | 21979893 | CNVD |
Ewing''s sarcoma | 21437220 | CNVD |
Autism | 19415332 | CNVD |
Malaria | 21533027 | CNVD |
Non-syndromic sensorineural hearing loss | 22037309 | CNVD |
Esophageal cancer | 21851588 | CNVD |
Gastric cancer | 17908304 | CNVD |
Acute promyelocytic leukemia | 19109227 | CNVD |
Breast cancer | 21245420 | CNVD |
T-cell prolymphocytic leukemia | 19278963 | CNVD |
Liver carcinoma | 19366792 | CNVD |
Seminomas | 18059402 | CNVD |
Acute lymphoblastic leukemia | 21390130 | CNVD |
Pancreatic cancer | 21811587 | CNVD |
Thyroid cancer | 19087340 | CNVD |
Myelofibrosis | 22110671 | CNVD |
Testicular cancer | 18059402 | CNVD |
Breast cancer | 17133270 | CNVD |
Breast cancer | 21509527 | CNVD |
Breast cancer | 21858162 | CNVD |
Acute lymphoblastic leukemia | 20435627 | CNVD |
Acute lymphoblastic leukemia | 21248843 | CNVD |
abnormal development | 18461090 | CNVD |
Oral cancer | 21386901 | CNVD |
Uveal melanoma | 21693616 | CNVD |
Langer-Giedion syndrome | 22283845 | CNVD |
Cancer | 21637783 | CNVD |
Splenic marginal zone lymphoma | 21957467 | CNVD |
Breast cancer | 20632083 | CNVD |
Breast cancer | 17603634 | CNVD |
Breast cancer | 19602461 | CNVD |
Cancer | 22429812 | CNVD |
Endometrial cancer | 22040021 | CNVD |
Esophageal squamous carcinoma | 21637470 | CNVD |
Glioblastoma multiforme | 19960244 | CNVD |
Glioblastoma multiforme | 21080181 | CNVD |
Hepatocellular carcinoma | 22174799 | CNVD |
Oral cancer | 19627613 | CNVD |
Prostate cancer | 21088497 | CNVD |
colon cancer | 17210682 | CNVD |
Breast cancer | 21264507 | CNVD |
Breast cancer | 22028636 | CNVD |
Acute myeloid leukemia | 16864856 | CNVD |
Cancer | 16751803 | CNVD |
Esophageal squamous carcinoma | 18350619 | CNVD |
Gastric cancer | 17167181 | CNVD |
Colorectal cancer | 19359472 | CNVD |
Breast cancer | 16461572 | CNVD |
Human rectal carcinomas | 16397240 | CNVD |
Medulloblastoma | 16968546 | CNVD |
head and neck squamous cell carcinoma | 18028549 | CNVD |
Breast cancer | 17001317 | CNVD |
Chronic lymphocytic leukemia | 21546498 | CNVD |
Acute myeloid leukemia | 20729466 | CNVD |
Ewing''s sarcoma | 17952124 | CNVD |
Urothelial carcinoma | 21177765 | CNVD |
Lung cancer | 18438408 | CNVD |
Breast cancer | 16608533 | CNVD |
Metanephric adenoma | 20802469 | CNVD |
Hepatocellular carcinoma | 18803288 | CNVD |
Prostate cancer | 18632612 | CNVD |
Ovarian cancer | 22174824 | CNVD |
Prostate cancer | 16573809 | CNVD |
Malignant peripheral nerve sheath tumor | 18522746 | CNVD |
Adenocarcinoma | 21044232 | CNVD |
Squamous cell cancer | 20885788 | CNVD |
T-cell prolymphocytic leukemia | 17713554 | CNVD |
Prostate cancer | 16461572 | CNVD |
Breast cancer | 21399628 | CNVD |
High-grade prostatic intraepithelial neoplasia | 16573809 | CNVD |
Acute lymphoblastic leukemia | 17690704 | CNVD |
Breast cancer | 17393978 | CNVD |
Burkitt''s lymphoma | 18698080 | CNVD |
Non-syndromic sensorineural hearing loss | 20606397 | CNVD |
Breast cancer | 17899364 | CNVD |
Acute myeloid leukemia | 21251322 | CNVD |
lymphocytic leukemia | 21291569 | CNVD |
Endometrioid adenocarcinoma | 16974079 | CNVD |
Developmental delay | 21147756 | CNVD |
Hodgkin''s lymphoma | 17606441 | CNVD |
Congenital diaphragmatic hernia | 21525063 | CNVD |
Non-small cell lung cancer | 19010865 | CNVD |
small cell lung cancer | 20016488 | CNVD |
Papillary thyroid cancer | 17515504 | CNVD |
Basal cell lymphoma | 17053054 | CNVD |
Gastric cancer | 21528007 | CNVD |
Breast cancer | 22532251 | CNVD |
Cervical cancer | 21062161 | CNVD |
Cancer | 21129771 | CNVD |
benign familial neonatal convulsions | 18472482 | CNVD |
Breast cancer | 16417655 | CNVD |
Astrocytoma | 17387387 | CNVD |
Cancer | 21183584 | CNVD |
Follicular lymphoma | 20505157 | CNVD |
T-cell lymphomas | 19863542 | CNVD |
Colorectal cancer | 20709793 | CNVD |
Medulloblastoma | 20607354 | CNVD |
Breast cancer | 20814816 | CNVD |
Colorectal cancer | 22486879 | CNVD |
Breast cancer | 17908964 | CNVD |
Colorectal cancer | 20031965 | CNVD |
Hepatocellular carcinoma | 16750200 | CNVD |
Ovarian cancer | 17908964 | CNVD |
Ovarian cancer | 20031965 | CNVD |
Prostate cancer | 20031965 | CNVD |
Non-small cell lung cancer | 17643093 | CNVD |
Prostate cancer | 19242612 | CNVD |
Colorectal cancer | 16774939 | CNVD |
Malignant melanoma | 17260012 | CNVD |
Diffuse large b-cell lymphoma | 18287131 | CNVD |
Acute myeloid leukemia | 17268525 | CNVD |
Acute myeloid leukemia | 18379011 | CNVD |
Esophageal squamous carcinoma | 18405350 | CNVD |
Chronic lymphocytic leukemia | 20421269 | CNVD |
low-grade B-cell lymphoma tumor | 18367492 | CNVD |
Sezary syndrome | 18413736 | CNVD |
Breast cancer | 22048815 | CNVD |
Colorectal cancer | 16912164 | CNVD |
Cutaneous T-cell lymphoma | 21881587 | CNVD |
Lung adenocarcinoma | 21148746 | CNVD |
Lung cancer | 21911935 | CNVD |
Breast cancer | 20459607 | CNVD |
Medulloblastoma | 19270706 | CNVD |
Acute myeloid leukemia | 19651601 | CNVD |
Colorectal cancer | 21645411 | CNVD |
Congenital anomalies of the kidney and urinary tract | 18316590 | CNVD |
Colorectal cancer | 19455253 | CNVD |
Glioblastoma multiforme | 22286061 | CNVD |
Colorectal cancer | 22860045 | CNVD |
Esophageal squamous carcinoma | 17470683 | CNVD |
Lung cancer | 17925434 | CNVD |
Non-small cell lung cancer | 21829676 | CNVD |
Prostate cancer | 17217626 | CNVD |
Cancer | 17160897 | CNVD |
Breast cancer | 16497871 | CNVD |
Colorectal cancer | 16882699 | CNVD |
Cystic fibrosis | 19273617 | CNVD |
Chronic stroke | 19622162 | CNVD |
Chordoma | 18071362 | CNVD |
Breast cancer | 17850661 | CNVD |
head and neck squamous cell carcinoma | 16740747 | CNVD |
Gastric cancer | 22539939 | CNVD |
Breast cancer | 16272173 | CNVD |
Uveal melanoma | 20484589 | CNVD |
Ovarian cancer | 20844748 | CNVD |
Multiple myeloma | 16616336 | CNVD |
Breast cancer | 16620391 | CNVD |
Acute lymphoblastic leukemia | 21098271 | CNVD |
Acute lymphoblastic leukemia | 18458336 | CNVD |
Breast cancer | 21364760 | CNVD |
Breast cancer | 21611746 | CNVD |
Non-syndromic sensorineural hearing loss | 18451855 | CNVD |
No. | Chromosome Location | Chromatin state | Cell line | Tissue |
---|---|---|---|---|
1 | chr8:130490200-130503400 | Weak transcription | Dnd41 | blood |
2 | chr8:130495600-130497600 | Enhancers | Primary monocytes fromperipheralblood | blood |
3 | chr8:130495600-130499600 | Genic enhancers | K562 | blood |
4 | chr8:130496600-130497400 | Enhancers | H1 Derived Neuronal Progenitor Cultured Cells | ES cell derived |
5 | chr8:130496800-130497400 | Enhancers | HUES6 Cell Line | embryonic stem cell |
6 | chr8:130496800-130497400 | Enhancers | iPS-18 Cell Line | embryonic stem cell |
7 | chr8:130496800-130497400 | Enhancers | Cortex derived primary cultured neurospheres | brain |
8 | chr8:130496800-130497600 | Enhancers | HUES48 Cell Line | embryonic stem cell |
9 | chr8:130496800-130497600 | Enhancers | Primary hematopoietic stem cells G-CSF-mobilized Male | -- |
10 | chr8:130496800-130497600 | Enhancers | Foreskin Melanocyte Primary Cells skin03 | Skin |
11 | chr8:130497000-130497400 | Enhancers | ES-UCSF4 Cell Line | embryonic stem cell |
12 | chr8:130497000-130497400 | Enhancers | Primary hematopoietic stem cells short term culture | blood |
13 | chr8:130497000-130497400 | Enhancers | Primary hematopoietic stem cells G-CSF-mobilized Female | -- |
14 | chr8:130497000-130497400 | Enhancers | Ganglion Eminence derived primary cultured neurospheres | brain |
15 | chr8:130497000-130497600 | Enhancers | hESC Derived CD184+ Endoderm Cultured Cells | ES cell derived |
16 | chr8:130497200-130497400 | Enhancers | H1 BMP4 Derived Trophoblast Cultured Cells | ES cell derived |
17 | chr8:130497200-130497400 | Enhancers | H9 Cell Line | embryonic stem cell |
18 | chr8:130497200-130497400 | Enhancers | Colon Smooth Muscle | Colon |
19 | chr8:130497200-130497400 | Enhancers | Monocytes-CD14+_RO01746 | blood |
20 | chr8:130497200-130497600 | Enhancers | Fetal Muscle Leg | muscle |
21 | chr8:130497200-130498400 | Enhancers | hESC Derived CD56+ Ectoderm Cultured Cells | ES cell derived |
22 | chr8:130497200-130504200 | Weak transcription | Thymus | Thymus |
23 | chr8:130497400-130497600 | Flanking Active TSS | Monocytes-CD14+_RO01746 | blood |
24 | chr8:130497600-130499000 | Weak transcription | Fetal Muscle Leg | muscle |
25 | chr8:130497600-130500800 | Weak transcription | Primary monocytes fromperipheralblood | blood |
26 | chr8:130497600-130501000 | Weak transcription | Monocytes-CD14+_RO01746 | blood |
27 | chr8:130497600-130503600 | Weak transcription | Foreskin Melanocyte Primary Cells skin03 | Skin |